qutaiba manaseer

market access lead gcc

About

Market Access Lead for GSK in the GCC region, focusing on innovation in Respiratory, Rare Diseases and Specialty lines at GSK. I have more than 13 years of commercial experience of which I spent 7 years as Sales Manager and led teams in different markets; Dubai, Abu Dhabi and Al Ain in UAE, and previously in Jordan. Therapeutic areas involved are Vaccines, Respiratory, Antibiotics, Diabetes, Anti Coagulants, CNS, HIV, Hepatitis & Derma. During which I led 24 medical reps which enriched my leadership capabilities and enabled me to tailor my leadership style according to their unique personalities, experiences and backgrounds. Specialties: Market Access, Sales, Tender, Commercial.

Country

united arab emirates

City

united arab emirates

Industry

pharmaceuticals

Skill

diabetes, therapeutic areas, hospitals, asthma, pharmaceutical sales, pharmaceutical industry, sales effectiveness, market access, pharmaceutics, strategy, cardiology, product launch, neurology, market analysis, leadership, kol development, hospital sales, gastroenterology, endocrinology, clinical trials, urology, sales management, market planning

Experience

supervisor-respiratory

gsk

2012-2 - 2013-1 · 1 yr

led the respiratory team in Abu Dhabi, It was very challenging year but we succeeded to grow Seretide in the respiratory market and to exceed Symbicort in the IMS for the 1st time.

team leader-diabetes

gsk

2009-11 - 2010-10 · 1 yr

* Though 2010 was full of challenges for Avandia, starting from the popular NY times article (Feb 2010) to the Recall that happened in September * yet a growth of 60% was achieved * and we exceeded the YTD target by 36%.

senior med representative

gsk

2009-4 - 2009-11 · 8 mos

Responsible for promoting Avandia in both tender and private sectors in Abu Dhabi.

market access manager

gsk

2016-11 - 2018-6 · 1 yr 8 mos

medical representative

gsk

2005-6 - 2009-3 · 3 yrs 10 mos

I have started my career in GSK-Jordan in 2005, as a med. rep. in the Augmentin team. In 2006, We achieved 132% vs the full year target which was the highest in GNE region. Later i joined Avandia team; The most strategic line in GSK at that time. In Feb. 2008, I moved to GSK-Abu Dhabi to join the institutional team their, I was responsible for Augmentin & Avandia.

gsk al ain sales manager

gsk

2013-1 - 2015-3 · 2 yrs 3 mos

leading gsk team in Al Ain, and managing the sales, supply and financial aspects of the business both in the trade and the tender .

team leader-cns, hospital line and derma

gsk

2010-10 - 2012-1 · 1 yr 4 mos

after Avandi recall, i was responsible for a team of 4 lines: CNS, Hospital line, Derma, and Pharma 2. It was very successful year as all the lines achieved their targets, Keppra and Lamictal market share exceeded 50% of the antiepileptic market (IMS 2011) and Arixtra penetrated the anticoagulants market and grew significantly.